Lv5
1040 积分 2026-04-15 加入
73rd Annual Meeting of the Medical Society of Toho University Professor Special Lecture The History of Ulcerative Colitis Revealed by the Literature
2天前
已关闭
Etrasimod: First Approval
3天前
已完结
S10 Outcomes of Early Versus Delayed Advanced Therapy Among Patients With Moderate Ulcerative Colitis in the United States: TARGET-IBD
4天前
已关闭
Mo1529 MIRIKIZUMAB IS EFFICACIOUS IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE AFTER ONE PRIOR ANTI-TNF FAILURE
5天前
待确认
Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis
6天前
已关闭
Atopic dermatitis is associated with the clinical course of inflammatory bowel disease
10天前
已完结
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn’s disease
13天前
已完结
Tracking MAPK-Dependent CD38 Upregulation by All-Trans Retinoic Acid in Human Leukemia Using 89Zr Immuno-PET
16天前
已关闭
Su1650 REAL WORLD EXPERIENCE WITH MIRIKIZUMAB IN THE TREATMENT OF HIGHLY REFRACTORY AND PRETREATED ULCERATIVE COLITIS. INTERIM-ANALYSIS FROM A LARGE EUROPEAN TERTIARY CENTER POPULATION
16天前
已关闭
Early real-world effectiveness of mirikizumab in a difficult-to-treat ulcerative colitis cohort
16天前
已关闭
皖公网安备34019202002308
